Rapid Infusion of Rituximab in a Heterogenous Pediatric Population: Safety and Feasibility

J Pediatr Hematol Oncol. 2016 Jan;38(1):83-5. doi: 10.1097/MPH.0000000000000480.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Feasibility Studies
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Infusions, Intravenous
  • Male
  • Rituximab / administration & dosage*
  • Young Adult

Substances

  • Antineoplastic Agents
  • Immunologic Factors
  • Rituximab